dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-12-03T13:08:40Z
dc.date.available2014-12-03T13:08:40Z
dc.date.created2014-12-03T13:08:40Z
dc.date.issued2013-10-11
dc.identifierBmc Veterinary Research. London: Biomed Central Ltd, v. 9, 6 p., 2013.
dc.identifier1746-6148
dc.identifierhttp://hdl.handle.net/11449/111464
dc.identifier10.1186/1746-6148-9-205
dc.identifierWOS:000326636000002
dc.identifierWOS000326636000002.pdf
dc.description.abstractBackground: Cancer stem cells (CSCs) are able to self-renew and to form metastases. Using flow cytometry, CSCs were detected in canine mammary tumors as cells CD44(+) and CD24(-). The aim of this study was to detect these CSCs by immunohistochemistry and correlate their frequency with canine mammary neoplasm grade and histopathological type. 130 mammary neoplasm samples were selected from tissue blocks at the Department of Pathology at UNESP and classified according to (BJVP 4:153-180, 2011). These samples were composed by adenomas, lymph node metastases, solid carcinomas grades II and III, tubular, papillary and carcinomas in mixed tumor grades I, II and III. Immunohistochemistry was performed with antibodies against CD44 and CD24. Linear regression was performed using Pearson's correlation test.Results: The value at CD44 was positive and CD24 becomes zero was 46.75%. Cells with a CD44(+)/CD24(-) phenotype were detected in 40 out of 130 samples with an advantage of high grade tumors (II and III) and metastases among tubular, papillary and carcinomas in mixed tumors. In these samples, percentages of cells stained by CD44 and CD24 antibodies were 62.2% and 0%, respectively. Published reports usually correlate grade III tumors with the expression of CD44 but not with CD24 expression. Studies using flow cytometry have found CSC frequencies similar to those found in our study.Conclusions: Immunohistochemistry was found to be a reliable technique for the detection of CSCs in canine mammary neoplasms, and the frequency of these cells positively correlates with grades II and III tumors (poor prognosis).
dc.languageeng
dc.publisherBiomed Central Ltd.
dc.relationBMC Veterinary Research
dc.relation1.958
dc.relation0,934
dc.rightsAcesso aberto
dc.sourceWeb of Science
dc.subjectCancer stem cells
dc.subjectCD44
dc.subjectCD24
dc.subjectCanine neoplasia
dc.subjectOncology
dc.subjectMammary neoplasia
dc.subjectCanine
dc.subjectStem cell
dc.titleImmunodetection of cells with a CD44+/CD24-phenotype in canine mammary neoplasms
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución